These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 7861228)

  • 21. Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.
    Pradilla G; Legnani FG; Petrangolini G; Francescato P; Chillemi F; Tyler BM; Gaini SM; Brem H; Olivi A; DiMeco F
    Neurosurgery; 2005 Nov; 57(5):1032-40; discussion 1032-40. PubMed ID: 16284573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
    Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
    J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.
    Lesniak MS; Upadhyay U; Goodwin R; Tyler B; Brem H
    Anticancer Res; 2005; 25(6B):3825-31. PubMed ID: 16312042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma.
    Ewend MG; Sampath P; Williams JA; Tyler BM; Brem H
    Neurosurgery; 1998 Nov; 43(5):1185-93. PubMed ID: 9802862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
    Emerich DF; Winn SR; Snodgrass P; LaFreniere D; Agostino M; Wiens T; Xiong H; Bartus RT
    Pharm Res; 2000 Jul; 17(7):776-81. PubMed ID: 10990194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.
    Brem H; Piantadosi S; Burger PC; Walker M; Selker R; Vick NA; Black K; Sisti M; Brem S; Mohr G
    Lancet; 1995 Apr; 345(8956):1008-12. PubMed ID: 7723496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
    Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
    J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
    Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
    J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole.
    Khalid MH; Tokunaga Y; Caputy AJ; Walters E
    J Neurosurg; 2005 Jul; 103(1):79-86. PubMed ID: 16121977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
    Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
    Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H
    Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.
    Emerich DF; Winn SR; Hu Y; Marsh J; Snodgrass P; LaFreniere D; Wiens T; Hasler BP; Bartus RT
    Pharm Res; 2000 Jul; 17(7):767-75. PubMed ID: 10990193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.
    DiMeco F; Li KW; Tyler BM; Wolf AS; Brem H; Olivi A
    J Neurosurg; 2002 Nov; 97(5):1173-8. PubMed ID: 12450040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
    Westphal M; Hilt DC; Bortey E; Delavault P; Olivares R; Warnke PC; Whittle IR; Jääskeläinen J; Ram Z
    Neuro Oncol; 2003 Apr; 5(2):79-88. PubMed ID: 12672279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
    Wu MP; Tamada JA; Brem H; Langer R
    J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
    Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
    Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA
    J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
    Zhang RX; Dougherty DV; Rosenblum ML
    Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.